Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC Keeping it real board for pro and con discussions -- Ignore unavailable to you. Want to Upgrade?

To: Rawnoc who wrote (28)	12/19/2014 11:03:54 AM
From: drkaz	Read Replies (1) \| Respond to of 326

IMO - I think that the wording chosen in making that statement about a lack of 'pipeline' was deliberate - and designed to make at least some people think that there was no pipeline. If I am incorrect in this assessment - then my apoligies for jumping to that conclusion. So - it's not a semantic argument that I am making by pointing out that the wording chosen was incorrect. It's an attempt to point out a what might have been a potential attempt at misdirection, or a lack of understanding of what a 'pipeline' actually was. And - technically - there are 'drugs' in the 'human clinical pipeline'. They are just not in the part of that pipeline where they are being tested on humans yet. TOX testing and the IND for Flucide IV are the last steps needed to get into that 'human clinical' part of the pipeline.